The North American anti-HA antibody market is to generate the highest revenue with a percentage of around 36% by the end of 2037. The APAC region will also encounter a significant surge in the anti-HA antibody market during the projected period. This surge will primarily be seen due to the prevalence of old aged people in this region. In fact, the